GGrantIndex
← Leaderboards

J. Thomas Thomas August

Johns Hopkins University

$11,740,601
Attributed
$11,740,601
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.8M · FY200511
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$11,740,601 · 5

By mechanism

U19$6,819,717 · 1
R37$4,110,855 · 1
R01$620,529 · 1
R03$163,500 · 1
RC1$26,000 · 1

Top collaborators

No co-investigators on record.

Most similar at Johns Hopkins University

Same institution · by research overlap

Others in their field

Top investigators on “Lysosomes

Research focus

LysosomesChimeric ProteinsMembrane ProteinsPrimatesAntigen PresentationVaccine DevelopmentMhc Class Ii AntigenDendritic CellsLaboratory MouseVector VaccineProtein TransportClinical ResearchResponseAntibodiesProgramsProteinsTissue /Cell CultureChimera OrganismAntigensDengue VirusPlasmidsCd4 Positive T LymphocytesDesignAntigen-Presenting Cells

Grant awards (20)

HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$394,207
R37 · FY2011 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$398,189
R37 · FY2010 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$402,210
R37 · FY2009 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$402,210
R37 · FY2008 · AI · contact PI
Dengue Epitope Vaccine,Tetravalent & MHCII-Targeted$1,401,389
U19 · FY2007 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$409,896
R37 · FY2007 · AI · contact PI
Dengue Epitope Vaccine,Tetravalent & MHCII-Targeted$1,407,793
U19 · FY2006 · AI · contact PI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$399,144
R37 · FY2006 · AI · contact PI
Dengue Epitope Vaccine,Tetravalent &MHCII-Targeted$1,424,623
U19 · FY2005 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$408,750
R37 · FY2005 · AI
Dengue Epitope Vaccine,Tetravalent &MHCII-Targeted$1,523,567
U19 · FY2004 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$408,750
R37 · FY2004 · AI
Dengue Epitope Vaccine,Tetravalent &MHCII-Targeted$1,062,345
U19 · FY2003 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$478,749
R37 · FY2003 · AI
HIV-1 Gene Products/Targeted/MHC II Antigen Presentation$408,750
R37 · FY2002 · AI
HIV-1 GENE PRODUCTS TARGETED TO MHC II ANTIGEN PRESENTAT$322,904
R01 · FY2001 · AI
ADVANCES IN DNA VACCINES AGAINST EBOLA &DENGUE VIRUSES$81,750
R03 · FY2001 · AI
HIV-1 GENE PRODUCTS TARGETED TO MHC II ANTIGEN PRESENTAT$297,625
R01 · FY2000 · AI
ADVANCES IN DNA VACCINES AGAINST EBOLA &DENGUE VIRUSES$81,750
R03 · FY2000 · AI
NOVEL TECHNOLOGIES APPLIED TO A DENQUE DNA VACCINE$26,000
RC1 · FY2000 · AI